CrossRef The association of hepatic steatosis and fibrosis with heart failure and mortality Jiyun Park, Gyuri Kim, Hasung Kim, Jungkuk Lee, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim Cardiovascular Diabetology.2021;[Epub] CrossRef Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease Seung Joon Choi, Seong Min Kim, Yun Soo Kim, Oh Sang Kwon, Seung Kak Shin, Kyoung Kon Kim, Kiyoung Lee, Ie Byung Park, Cheol Soo Choi, Dong Hae Chung, Jaehun Jung, MunYoung Paek, Dae Ho Lee Diabetes & Metabolism Journal.2021
Options include adjusting your GLP-1 dose, slowing your titration schedule, or switching formulationsfor example, from Semaglutide Injection to Oral Semaglutide or trying Microdose GLP-1 Protocol
Prolonged exposure could contribute to more severe neurological conditions
These are signs the medication is working